Prozomix CAP Programme extended - Prozomix
Scientist

Prozomix CAP Programme extended

After successfully launching its Commercial Academic Partner (CAP) Programme, Prozomix is now expanding this area of its business by offering to partner with any academic looking to exploit their recombinant enzyme / protein expression clones.

After successfully launching its Commercial Academic Partner (CAP) Programme, Prozomix is now expanding this area of its business by offering to partner with any academic looking to exploit their recombinant enzyme / protein expression clones. Under the terms of the CAP agreement, the academic (their institution) will receive a very generous royalty payment of 17.5% on all sales, with Prozomix being responsible for all aspects (and costs) of the production, preparation and sale of the products.